Company: CMND
Filing Date: 2025-11-26
Form Type: F-1
Source: 0001213900-25-115501
Chunk: 27

Company: Clearmind Medicine Inc.
Filing Date: 2025-11-26
Form: F-1
Chunk 27
---
 pre-funded warrant for net proceeds of $738,000, after deducting offering expenses payable by us, (iii) the issuance and sale of 5,509,768 Common Shares and/or pre-funded warrants in the Second November 2025 Offering at a public offering price of $0.25 per Common Share and $0.2499 per pre-funded warrant for net proceeds of approximately $1.3 million, after deducting offering expenses payable by us, (iv) the issuance and sale of 10,925,000 Common Shares in the Third November 2025 Offering at a public offering price of $0.25 per Common Share for net proceeds of approximately $2.1 million, after deducting offering expenses payable by us, , and (v) the issuance of 2,090,987 Common Shares for aggregate gross proceeds of approximately $183,000 as a result of the exercise of warrants to purchase 2,894,769 Common Shares for cash and on a cashless basis issued in our financings in April 2023 and January 2024, as if such events had occurred on July 31, 2025. |

You should read this information in conjunction
with our consolidated financial statements and the related notes appearing at the end of this prospectus and the “Management’s
Discussion and Analysis of Financial Condition and Results of Operations” section and other financial information contained in this
prospectus.

|                                      |     | As of  July 31, 
 2025            |         |   |     |       |         |   |
|:-------------------------------------|:----|:----------------|--------:|:--|:----|:------|--------:|:--|
| U.S. dollars in thousands            |     | Actual          |         |   |     | Pro   
 Forma |         |   |
| Cash and cash equivalents            |     | $               |   3,495 |   |     | $     |  10,128 |   |
| Derivative warrants liability        |     |                 |  (2,179 | ) |     |       |  (1,782 | ) |
| Shareholders’ equity:                |     |                 |         |   |     |       |         |   |
| Share capital and share premium      |     |                 |  25,570 |   |     |       |  32,360 |   |
| Warrants                             |     |                 |     459 |   |